Recon: FDA warns of shortages of asthma med albuterol; Bayer plans $1B spend on US pharma R&D in 2023

Recon

ReconJoanne S. Eglovitch

Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy